Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



GEN Poll

 More »
Jan 05, 2012

Clinical Sequencing

Do you think personal sequencing platforms will enter the clinical diagnostic arena this year?

Yes
 
  56.4%
No
 
  35.9%
Undecided
 
  7.7%

Suggest a Poll
More Polls » View Results »

Fast forwarding to the near future and based on the recent past, sequencing instrument companies will continue to develop more user-friendly and cheaper technology, focused on the benchtop and clinical markets. On a worldwide basis, research, discovery, and development applications comprise the two largest sequencing markets. By far the largest market opportunity, though, is in personal genomics and clinical diagnostics. These segments are expected to reach $541 million by 2015 from $15.5 million in 2010. Recent advancements in the field of next-generation sequencing have resulted in the advent of so-called personal genome machines. Companies aiming at the clinical space will need to gain regulatory approval for their use in clinical laboratory diagnostics. What do you think this year holds for sequencing technologies in the clinical space?

 

Related Content

GEN News Highlights

MORE RELATED GEN NEWS HIGHLIGHTS

Insight & Intelligence™

MORE RELATED INSIGHT & INTELLIGENCE™

GEN Articles

MORE RELATED GEN ARTICLES

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll